Asymmetric left ventricular (LV) hypertrophy, a prominent feature of hypertrophic cardiomyopathy (HCM), presents a significant diagnostic and therapeutic challenge. While concentric LV hypertrophy involves uniform thickening of the LV wall, asymmetric LV hypertrophy is characterized by disproportionate thickening of one part of the LV wall, most commonly the posterior wall, relative to other regions. This article will delve into the intricacies of asymmetric LV hypertrophy, exploring its morphological characteristics, associated electrocardiographic and echocardiographic findings, diagnostic approaches, treatment strategies, and prognostic implications.
The Defining Morphology: Posterior Wall Predominance
In 1991, Lewis JF and Maron BJ significantly advanced our understanding of HCM by describing a subgroup of patients exhibiting a distinct morphological pattern: marked, and often disproportionate, asymmetric posterior LV wall hypertrophy. This asymmetrical thickening contrasts sharply with the more uniform thickening observed in concentric LV hypertrophy. The posterior wall's disproportionate hypertrophy often involves the inferoposterior septum, creating a significant functional and anatomical imbalance within the LV chamber. This asymmetry impacts LV filling and ejection dynamics, leading to a cascade of hemodynamic consequences that contribute to the clinical presentation and prognosis of the condition. The precise mechanisms underlying this selective hypertrophy remain incompletely understood, but genetic predisposition, myocardial fiber disarray, and altered neurohormonal influences are likely contributing factors.
Left Ventricle Increased Wall Thickness: A Key Diagnostic Feature
The cornerstone of diagnosing asymmetric LV hypertrophy is the identification of increased LV wall thickness. Echocardiography, specifically two-dimensional (2D) echocardiography, plays a pivotal role in visualizing and quantifying this thickening. Measurements of LV wall thickness at various points, including the interventricular septum and the posterior wall, are crucial. Asymmetric hypertrophy is diagnosed when the posterior wall thickness significantly exceeds the septal thickness, often exceeding 15 mm in at least one segment. However, it's crucial to remember that the absolute thickness values can vary depending on factors such as age, body size, and loading conditions. Therefore, the ratio between posterior wall thickness and septal thickness is often considered more informative than absolute values alone. The presence of significant hypertrophy, particularly asymmetric hypertrophy, raises concerns about potential LV outflow tract obstruction (LVOTO), a common complication associated with adverse clinical outcomes.
Left Ventricular Hypertrophy and QRS Widening: Electrocardiographic Clues
Electrocardiography (ECG) provides valuable, albeit non-specific, clues to the presence of LV hypertrophy. In cases of asymmetric LV hypertrophy, the ECG often reveals QRS complex widening, reflecting the increased mass and altered conduction pathways within the hypertrophied myocardium. The specific ECG findings can be variable, depending on the extent and location of the hypertrophy. Deep and broad Q waves in the inferior leads (II, III, aVF) are frequently observed, reflecting the posterior wall involvement. Left axis deviation, left atrial enlargement, and ST-T wave abnormalities are also common findings. While ECG findings can suggest the presence of LV hypertrophy, echocardiography remains the gold standard for confirming the diagnosis and assessing the extent and pattern of hypertrophy. The ECG findings alone are insufficient for definitive diagnosis and should be interpreted in conjunction with echocardiographic data.
current url：https://sbhlfo.d793y.com/bag/asymmetric-lv-hypertrophy-94291